Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Coll Cardiol. 2014 Feb 18;63(6):537-8. doi: 10.1016/j.jacc.2013.09.057. Epub 2013 Oct 30.

Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysis.

Author information

  • 1University of Michigan School of Medicine, Ann Arbor, Michigan.
  • 2Inserm 9501 and 1116, Centre d'Investigations Cliniques, Nancy, France; CHU Nancy, Institut Lorrain du Coeur et des Vaisseaux, Vandoeuvre lès Nancy, Nancy, France; Université de Lorraine, Nancy, France; Association Lorraine pour le Traitement de l'Insuffisance Rénale, Vandoeuvre lès Nancy, Nancy, France. Electronic address: p.rossignol@chu-nancy.fr.

KEYWORDS:

cardiovascular and cerebrovascular event; hemodialysis; spironolactone

Comment on

PMID:
24184253
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk